Efficacy and Safety of Letermovir for <i>Cytomegalovirus</i> Prophylaxis in Pediatric Hematopoietic Stem Cell Transplantation Recipients: A Systematic Review, Meta‐Analysis, and Meta‐Regression

20257 citationsReview

Authors

Abdullah Yousef Aldalati · Jordan University of Science and Technology

Ayham Mohammad Hussein · Al-Balqa Applied University

Elsayed Balbaa · Alexandria University

Bara M. Hammadeh · Al-Balqa Applied University

Muhammad T. Idrees · Lahore General Hospital

Osama Aloudat · Cardinal Glennon Children’s Medical Center

Moath Albliwi

Abstract

LTV has demonstrated safety and efficacy in preventing CMV infection and disease among high-risk pediatric patients. Future large scale randomized trials are necessary to validate the findings.

Topics & Keywords

Cytomegalovirus and herpesvirus research Herpesvirus Infections and Treatments Mosquito-borne diseases and control

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Transplant Infectious Disease

Volume 27, Issue 2, pp. e70006-e70006

DOI: 10.1111/tid.70006

Field-Weighted Citation Impact: 9.59